Summary

As part of a £21.5m programme in Regenerative Medicine, the Technology Strategy Board is to invest up to £2m in collaborative research and development feasibility projects in the area of regenerative medicine tools and technologies.

Our aim is to help establish projects and future collaborations that will participate in larger initiatives in regenerative medicine to be run jointly in 2011 by the Technology Strategy Board, the Medical Research Council (MRC), the Biotechnology and Biological Sciences Research Council (BBSRC), and the Engineering and Physical Sciences Research Council (EPSRC).

Projects must be collaborative and led by a business, and proposals must clearly state the benefits to business. Project outputs must be either a technology or an application demonstrator, to be presented in a report and a formal presentation.

Challenge

To explore the feasibility of developing platform tools and technologies to overcome key development challenges in safety and efficacy testing, and the manufacturing of regenerative medicine therapeutics.